Thromboembolism Incidence and Risk Factors in Multiple Myeloma After First Exposure to Immunomodulatory Drug

Thromboembolism Incidence and Risk Factors in Multiple Myeloma After First Exposure to Immunomodulatory Drug–Based Regimens

Published:2021-03 Issue:3 Volume:21 Page:188-198.e2
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Patel Jai N.^ORCID,Robinson Myra^ORCID,Jagosky Megan,Slaughter Daniel,Arnall Justin,Jandrisevits Elizabeth,Matusz-Fisher Ashley^ORCID,Atrash Shebli^ORCID,Paul Barry,Bhutani Manisha,Voorhees Peter,Usmani Saad Z.

Funder

Janssen Pharmaceuticals Inc

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference19 articles.

1. Cancer-associated thrombosis;Karimi;Open Cardiovasc Med J,2010

2. How I treat cancer-associated venous thromboembolism;Kraaijpoel;Blood,2019

3. Prevalence and impact of venous and arterial thromboembolism in patients with embolic stroke of undetermined source with or without active cancer;Ha;J Am Heart Assoc,2019

4. Venous thromboembolism incidence in hematologic malignancies;Kekre;Blood Rev,2019

5. Thromboprophylaxis in multiple myeloma patients treated with lenalidomide—a systematic review;Al-Ani;Thromb Res,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extramedullary Pulmonary Manifestations of Relapsed/Refractory Multiple Myeloma: A Case Series and Brief Review of the Literature;Journal of Respiration;2024-09-02

2. Thromboprophylaxis in multiple myeloma: a case-based review with practical guidelines;Annals of Hematology;2024-04-17

3. Incidence of thromboembolism and associated factors in multiple myeloma patients treated with immunomodulatory drugs: a retrospective analysis in Belo Horizonte, Brazil;Supportive Care in Cancer;2023-12-16

4. Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival;American Journal of Hematology;2023-01

5. Abnormal metaphase cytogenetics predicts venous thromboembolism in myeloma: derivation and validation of the PRISM score;Blood;2022-12-08